MEDICAL TREATMENT OF SINONASAL INFLAMMATORY CONDITIONS
The advent of monoclonal antibody therapy has changed the treatment paradigm for the specialty of rheumatology, in which many treatments now specifically target mechanisms of autoimmune diseases. That approach has not been widely adopted in the treatment of chronic rhinosinusitis, but several monoclonal antibodies, including omalizumab, dupilumab, mepolizumab, and reslizumab, are emerging as therapeutic alternatives to conventional therapies of corticosteroids and even surgery. In this issue, Chiarella et al., 4 presented a comprehensive review of clinical trials of these agents for the treatment of specific chronic rhinosinusitis subtypes.
Lin 5 compared normal saline solution nasal-pharyngeal irrigation and fluticasone propionate nasal spray (FPNS) treatments in patients with allergic rhinitis due to house-dust mite. Cough, as measured by the Leicester Cough Questionnaire and the cough response to capsaicin, was improved among patients treated with normal saline solution nasal-pharyngeal irrigation but not with FPNS. However, visual analog scores of allergic rhinitis symptoms and mediators (histamine, leukotriene C4, prostaglandin D2, and major basic protein) from nasal lavage fluid were reduced more in the FPNS group.
The prevalence of respiratory viruses in the paranasal sinuses of patients with cystic fibrosis (CF) was examined by Rowan et al., 6 who used commercially available respiratory viral screens in a study of 24 patients with CF and 14 healthy controls. Respiratory virus was detected in 33% of patients with CF and 0% of controls, respiratory virus was only detected during the winter months, and the presence of respiratory virus was not associated with differences in the SNOT-22 scores or the modified Lund-Kennedy scores.
SURGICAL TREATMENT OF SINONASAL DISEASES
Roxbury et al., 7 noted that 66.7% of patients with acute invasive fungal rhinosinusitis survived their initial hospital stay in a retrospective review of 54 patients treated over a 30-year period. The authors proposed a surgical staging system: stage I, disease limited to the nasal cavity; stage II, disease that involves the paranasal sinuses; stage III, disease that extends to the orbit; and stage IV, disease that extends to skull base or the intracranial contents. Decreased likelihood of complete surgical resection was noted in state III (37.5%) and stage IV disease (16.7%) compared with stage I disease (90.9%); similarly, increasing disease stage was associated with a decreased likelihood of survival (stage I, 100%; stage II, 60%; stage III, 62.5%; stage IV, 54.6%).
Office-based rhinologic procedures are increasingly common, but reports of case series in the literature are relatively sparse. Scott et al., 8 described a single institution's experience with office-based rhinologic procedures in a case series of 315 patients who underwent 166 turbinoplasty, 118 ESS, 35 septoplasty, 34 rhinoplasty, and 4 septorhinoplasty surgeries. They concluded that the office-based procedures were safe, with a low rate of revision procedures.
SKULL BASE
Although minimally invasive pituitary surgery (MIPS) has emerged as the preferred modality for surgical treatment of pituitary pathology, optimal strategies for managing the postoperative cavity have not been determined. Chaudhry et al., 9 reported SNOT-22 scores and endoscopic data for 52 patients after MIPS. Scores on the SNOT-22 rhinologic domain worsened for the first 2 weeks after surgery and then improved back to baseline. Endoscopy scores showed a similar trend for up to 16 weeks after surgery. This lag highlighted the importance of serial endoscopy in the postoperative period to optimize long-term outcomes after MIPS.
Over the past 25 years, numerous materials have been proposed for the repair of skull base defects. Al-Asousi et al. 10 described the use of a polydioxanone plate in five patients who underwent skull base repair for tumor resection and two patients who underwent skull base repair for CSF rhinorrhea. This initial report highlighted a single center's preliminary experience with a resorbable but rigid implant for skull base reconstruction. Although the reported success rates for endoscopic CSF leak diagnosis and repair were quite good, certain characteristics of a skull base defect may make such diagnosis and repair more challenging. Loftus et al., 11 described the radiologic find-
ing of an "excavating/canal-like skull base defect," which they associated with difficulty in localizing the CSF leak as well as early recurrence after repair. Omura et al., 12 presented a video report on the trans-septal access with crossing multiple incisions, a method for both tumor transposition and pedicle visualization during endoscopic resection of unilateral sinonasal lesions. At many institutions, rhinologic surgeons are called to manage unusual instances of skull base trauma. Ghadersohi et al. 13 performed a systematic review of penetrating skull base injuries from the surgical rhinology perspective. In this review, fewer than half of the cases were managed under endoscopic visualization or with endoscopic assistance. Secondary morbidity was quite noteworthy, which thus highlighted the need for thorough and timely interdisciplinary management.
FUTURE WORK
Any reader of this month's American Journal of Rhinology and Allergy issue will be impressed by the quality and breadth of the articles. The authors should be congratulated for their contributions to rhinology. These efforts will improve the clinical care provided to today's patients as well as future patients. 
